[
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05412394",
        "briefTitle": "Once Weekly Infant Corticosteroid Trial for DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-04-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-06-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Anne M. Connolly"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03529240",
        "briefTitle": "Kinesiology Taping in Duchenne Muscular Dystrophy: Effects on Performance, Gait Characteristics, and Energy Consumption"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-06-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Performance",
          "Energy",
          "Gait",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01761292",
        "briefTitle": "A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-01-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02285673",
        "briefTitle": "Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2013-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-11-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-11-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Acibadem University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03589573",
        "briefTitle": "Effect of Muscle Strength on Hamstring Flexibility in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-03-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-07-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-07-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Muscle Strength",
          "Lower Extremity",
          "Hamstring Contractures"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01633866",
        "briefTitle": "Pediatric Radio Frequency Coils Generic"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2012-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-07-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital Medical Center, Cincinnati"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Musculoskeletal Abnormalities"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06491927",
        "briefTitle": "Long Term Follow-up for RGX-202"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2024-05-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-07-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "REGENXBIO Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01931644",
        "briefTitle": "At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-08-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sanguine Biosciences"
        }
      },
      "conditionsModule": {
        "conditions": [
          "All Diagnosed Health Conditions",
          "ADD/ADHD",
          "Alopecia Areata",
          "Ankylosing Spondylitis",
          "Asthma",
          "Atopic Dermatitis Eczema",
          "Beta Thalassemia",
          "Bipolar Disorder",
          "Breast Cancer",
          "Celiac Disease",
          "Cervical Cancer",
          "Chronic Inflammatory Demyelinating Polyneuropathy",
          "Chronic Kidney Diseases",
          "Chronic Obstructive Pulmonary Disease",
          "Colon Cancer",
          "Colorectal Cancer",
          "Crohn's Disease",
          "Cystic Fibrosis",
          "Depression",
          "Diabetes Mellitus",
          "Duchenne Muscular Dystrophy",
          "Endometriosis",
          "Epilepsy",
          "Facioscapulohumeral Muscular Dystrophy",
          "G6PD Deficiency",
          "General Anxiety Disorder",
          "Hepatitis B",
          "Hereditary Hemorrhagic Telangiectasia",
          "HIV/AIDS",
          "Human Papilloma Virus",
          "Huntington's Disease",
          "Idiopathic Thrombocytopenic Purpura",
          "Insomnia",
          "Kidney Cancer",
          "Leukemia",
          "Lung Cancer",
          "Lupus Nephritis",
          "Lymphoma",
          "Melanoma",
          "Multiple Myeloma",
          "Multiple Sclerosis",
          "Myositis",
          "Myotonic Dystrophy",
          "Ovarian Cancer",
          "Pancreatic Cancer",
          "Parkinson's Disease",
          "Polycystic Kidney Diseases",
          "Prostate Cancer",
          "Psoriasis",
          "Psoriatic Arthritis",
          "Rosacea",
          "Scleroderma",
          "Sickle Cell Anemia",
          "Sickle Cell Trait",
          "Sjogren's Syndrome",
          "Skin Cancer",
          "Spinal Muscular Atrophy",
          "Systemic Lupus Erythematosus",
          "Thrombotic Thrombocytopenic Purpura",
          "Trisomy 21",
          "Ulcerative Colitis"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03611244",
        "briefTitle": "Prevention of Scoliosis in Patients With Duchenne Muscular Dystrophy Using Portable Seat Device"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2018-08-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-08-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-09-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Seoul National University Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Scoliosis Neuromuscular",
          "Duchenne Muscular Dystrophy",
          "Lordosis Lumbar"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02780492",
        "briefTitle": "Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-04-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-05-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University College, London"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00873782",
        "briefTitle": "Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-04-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-03-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of North Carolina, Chapel Hill"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Limb-Girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03680365",
        "briefTitle": "Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-09-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-09-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-04-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Jett Foundation, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Burden, Dependency",
          "Disability Physical",
          "Disease Management",
          "Impairment",
          "Rare Diseases"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02436720",
        "briefTitle": "Upper Limb Assessment in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2013-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-05-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catholic University of the Sacred Heart"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06564974",
        "briefTitle": "Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE\u00ae) in Patients with Duchenne Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-07-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catalyst Pharmaceuticals, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03633565",
        "briefTitle": "Comparative Study of Strategies for Management of Duchenne Myopathy (DM)"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2018-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-08-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-08-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assiut University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Myopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00005574",
        "briefTitle": "Gentamicin Treatment of Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2000-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2002-12-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2008-03-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Institute of Neurological Disorders and Stroke (NINDS)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01826474",
        "briefTitle": "Phase IIb Study of PRO045 in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03675126",
        "briefTitle": "An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-12-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-09-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06363526",
        "briefTitle": "Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-05-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Malaga"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00207857",
        "briefTitle": "Test-Retest Reliability of Pulmonary Function Tests in Patients With Duchenne's Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2004-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-09-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-02-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Healthcare of Atlanta"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne's Muscular Dystrophy",
          "Scoliosis"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04322357",
        "briefTitle": "Twice Weekly Steroids and Exercise as Therapy for DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2020-07-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-03-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06363357",
        "briefTitle": "The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-04-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Seoul National University Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Orthotic Devices",
          "Upper Extremity"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05715957",
        "briefTitle": "Follow-up Study on Female Carriers With DMD Gene Variants"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2023-03-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-02-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-02-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Rigshospitalet, Denmark"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy",
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03552874",
        "briefTitle": "Pulmonary and Upper Limb Functions in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-01-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-06-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-06-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Upper Limb Function",
          "Respiratory Function Test"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04349566",
        "briefTitle": "Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-06-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-04-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mads Peter Godtfeldt Stemmerik"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "McArdle Disease",
          "Limb-Girdle Muscular Dystrophy Type 2"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01921374",
        "briefTitle": "Mother-caregivers of Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-08-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-02-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Monica Levy Andersen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Other Diseases or Conditions"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04626674",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-11-23"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-11-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00451074",
        "briefTitle": "Six Month Study of Gentamicin in Duchenne Muscular Dystrophy With Stop Codons"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2007-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2007-03-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2012-03-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04287582",
        "briefTitle": "The Evaluation of Muscle Activation in Climbing up Stairs Activity in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2019-04-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-02-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-02-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01847573",
        "briefTitle": "Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-05-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-09-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Processa Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02369731",
        "briefTitle": "Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2015-04-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-02-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02018731",
        "briefTitle": "L-citrulline and Metformin in Becker's Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-12-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-05-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Basel, Switzerland"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker's Muscular Dystrophy (BMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06244082",
        "briefTitle": "Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants with Mutations Amenable to Exon44 Skipping"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-01-22"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-02-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Avidity Biosciences, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "DMD",
          "Duchenne Muscular Dystrophy",
          "Duchenne",
          "Exon 44"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03703882",
        "briefTitle": "Phase III Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-10-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-10-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-06-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catabasis Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00981266",
        "briefTitle": "Spectra Breast Implant Study"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-09-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-03-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mentor Worldwide, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Augmentation",
          "Augmentation Revision",
          "General Breast Enlargement",
          "Post-lactational Involution",
          "Asymmetry"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02614820",
        "briefTitle": "The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-11-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-11-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "General Hospital of Chinese Armed Police Forces"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05281120",
        "briefTitle": "Effects of Low-level Mechanical Vibration on Bone Density in Ambulant Children Affected by Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2006-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Istituto Auxologico Italiano"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Osteoporosis",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02994030",
        "briefTitle": "Biomarker for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-08-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-12-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "CENTOGENE GmbH Rostock"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Increased Lordosis/Scoliosis",
          "Hyporeflexia",
          "Duchenne Muscular Dystrophy",
          "Red-Green Color Blindness",
          "Lordosis",
          "Scoliosis",
          "Muscular Atrophy",
          "Muscular Weakness"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05575648",
        "briefTitle": "Dual Task in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-09-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-10-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03992430",
        "briefTitle": "A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-07-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-06-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05639257",
        "briefTitle": "Treatment of Myotonia - Lamotrigine Versus Namuscla"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-12-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-12-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-12-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Grete Andersen, MD"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Non-Dystrophic Myotonia"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02819557",
        "briefTitle": "Study of Ataluren in \u22652 to <5 Year-Old Male Participants With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-06-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-06-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-08-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04129294",
        "briefTitle": "Exploratory Study of NS-089/NCNP-02 in DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-12-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-10-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Center of Neurology and Psychiatry, Japan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02710591",
        "briefTitle": "Rimeporide in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-03-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-07-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "EspeRare Foundation"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02295748",
        "briefTitle": "An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-11-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03319030",
        "briefTitle": "Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-09-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-10-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-02-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ann & Robert H Lurie Children's Hospital of Chicago"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04687020",
        "briefTitle": "Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2021-06-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-12-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-10-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04184882",
        "briefTitle": "A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2021-02-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-12-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Astellas Pharma Inc"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02310763",
        "briefTitle": "A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2014-11-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-12-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-12-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05933057",
        "briefTitle": "Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-02-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-07-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06594094",
        "briefTitle": "An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-10-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-09-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "HuidaGene Therapeutics Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophin (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04906460",
        "briefTitle": "Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2021-09-28"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-05-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Wave Life Sciences Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02434627",
        "briefTitle": "Sodium Nitrate for Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-05-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-01-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02484560",
        "briefTitle": "Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-06-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-07-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Gaziantep"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04139460",
        "briefTitle": "CRT-P or CRT-D in Dilated Cardiomyopathy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2020-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-10-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-03-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital Olomouc"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Cardiomyopathy, Dilated, 3B"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02078076",
        "briefTitle": "IRM Cardiaque en Respiration Libre Pour Des Patients Atteints de Dystrophinopathie s\u00e9v\u00e8re"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-03-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-02-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne or Severe Becker Myopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05305976",
        "briefTitle": "Telerehabilitation in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-01-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Karadeniz Technical University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02418338",
        "briefTitle": "2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy Children"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-04-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-06-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Montpellier"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01772043",
        "briefTitle": "Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2012-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-01-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-07-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02037243",
        "briefTitle": "Disgust and Shame Based Safe Water and Handwashing Promotion"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-01-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-06-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "International Centre for Diarrhoeal Disease Research, Bangladesh"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Develop a New Group Version of the Becker-DeGroot-Marsckek (BDM) Auction to Measure Willingness to Pay of Compound Members for Shared Hardware.",
          "Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.",
          "Identify New Methods for Measuring Hand Washing and Water Treatment Behaviour.",
          "Compare the Effectiveness of the Disgust and Shame Based Interventions With Standard Public Health Interventions."
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06109103",
        "briefTitle": "Telerehabilitation-based Motor Imagery Training in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2023-12-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06378203",
        "briefTitle": "Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-12-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "IRCCS Eugenio Medea"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Limb Girdle Muscular Dystrophy",
          "Facio-Scapulo-Humeral Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05291091",
        "briefTitle": "Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03689660",
        "briefTitle": "Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2019-02-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-09-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-06-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Merve Kurt"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Neuromuscular Disease",
          "Duchenne Muscular Dystrophy",
          "Spinal Muscular Atrophy",
          "Virtual Reality",
          "Biofeedback"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00759876",
        "briefTitle": "Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2008-08-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-09-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-10-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03067831",
        "briefTitle": "Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-03-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-03-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Stem Cells Arabia"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03882827",
        "briefTitle": "Natural History of Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2019-12-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-03-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Genethon"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03648827",
        "briefTitle": "A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-12-21"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-08-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-04-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05257473",
        "briefTitle": "Defining Endpoints in Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-04-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-02-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Virginia Commonwealth University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Muscular Dystrophies",
          "Muscular Dystrophy in Children",
          "Muscular Dystrophy, Becker"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03179631",
        "briefTitle": "Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-06-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophies",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Musculoskeletal Disease",
          "Neuromuscular Diseases",
          "Nervous System Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05540860",
        "briefTitle": "A Study of EDG-5506 in Children with Duchenne Muscular Dystrophy (LYNX)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-10-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-09-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06224660",
        "briefTitle": "Modulation of SERCA2a of Intra-Myocytic Calcium Trafficking in Cardiomyopathy Secondary to Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-01-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sardocor Corp."
        }
      },
      "conditionsModule": {
        "conditions": [
          "DMD-Associated Dilated Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04428476",
        "briefTitle": "Open-label Extension of the HOPE-2 Trial"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-07-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-06-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Capricor Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01009294",
        "briefTitle": "Study of Ataluren (PTC124) in Nonambulatory Participants With Nonsense-Mutation-Mediated Duchenne/Becker Muscular Dystrophy (nmDMD/BMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2010-01-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-11-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-07-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05429372",
        "briefTitle": "Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2022-08-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-06-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04254172",
        "briefTitle": "A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2020-02-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-02-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-10-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01753804",
        "briefTitle": "A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2012-09-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-12-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03907072",
        "briefTitle": "Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2019-09-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-04-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-05-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Wave Life Sciences Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05464446",
        "briefTitle": "Examination of Lower Urinary System Symptoms With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-10-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-07-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-07-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Lokman Hekim \u00dcniversitesi"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Lower Urinary Tract Symptoms",
          "Muscle Weakness",
          "Posture Disorders in Children",
          "Lumbar Lordosis",
          "Pelvic Floor Muscle Weakness",
          "Quality of Life"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02740972",
        "briefTitle": "Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-04-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03879304",
        "briefTitle": "Effectiveness of a Multimodal Physiotherapy Program With Virtual Reality Glasses in Duchenne and Becker."
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-03-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-03-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Malaga"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne and Becker Types"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04972604",
        "briefTitle": "CureDuchenne Link\u00ae: A Resource for Research"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-07-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-07-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "CureDuchenne"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00033189",
        "briefTitle": "An Open-label Pilot Study of Coenzyme Q10 in Steroid-Treated Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2001-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2002-04-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2010-11-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03406780",
        "briefTitle": "A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-03-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-01-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-06-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Capricor Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Muscular Dystrophy, Duchenne",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Neuromuscular Diseases",
          "Nervous System Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03373968",
        "briefTitle": "Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2017-10-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01539772",
        "briefTitle": "Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2012-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-02-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-06-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05688072",
        "briefTitle": "Trunk Oriented Exercises Versus Whole-body Vibration for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2023-01-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-04-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cairo University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne Type"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01183767",
        "briefTitle": "Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-12-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-08-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-07-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Charite University, Berlin, Germany"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01834040",
        "briefTitle": "Study Safety and Efficacy of BMMNC for the Patient With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2014-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-09-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Chaitanya Hospital, Pune"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04632940",
        "briefTitle": "Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2021-03-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-11-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "FibroGen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01610440",
        "briefTitle": "Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2011-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-06-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2012-11-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Shenzhen Beike Bio-Technology Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00243789",
        "briefTitle": "Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2005-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-10-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04956289",
        "briefTitle": "Study to Assess the Safety, Tolerability, and Efficacy of Viltolarsen in Ambulant and Non-Ambulant Boys With DMD (Galactic53)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-07-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-07-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02109692",
        "briefTitle": "Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2014-05-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-04-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Montpellier"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Becker Muscular Dystrophy",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03236662",
        "briefTitle": "(-)- Epicatechin Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-08-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-11-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Craig McDonald, MD"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04782440",
        "briefTitle": "The Effect of Telerehabilitation of Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2021-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-03-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-03-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Marmara University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01462292",
        "briefTitle": "A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-10-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-10-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04353167",
        "briefTitle": "Examination of the Relationship Between Foot - Body Posture and Balance and Gait in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-03-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-04-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-07-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Foot Posture",
          "Balance",
          "Gait Disorders, Neurologic",
          "Body Posture"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06606340",
        "briefTitle": "A Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2019-01-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-09-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02636686",
        "briefTitle": "Extension Study of Drisapersen in DMD Subjects"
      },
      "statusModule": {
        "overallStatus": "NO_LONGER_AVAILABLE",
        "studyFirstPostDateStruct": {
          "date": "2015-12-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-01-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02315339",
        "briefTitle": "European Home Mechanical Ventilation Registry"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2014-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-12-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-04-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ResMed"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Pulmonary Disease, Chronic Obstructive",
          "Amyotrophic Lateral Sclerosis",
          "Spinal Cord Injury",
          "Muscular Dystrophies",
          "Obesity Hypoventilation Syndrome",
          "Kyphoscoliosis",
          "Congenital Central Hypoventilation Syndrome",
          "Duchenne Muscular Dystrophy",
          "Myopathies",
          "Myotonic Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03039686",
        "briefTitle": "Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-02-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-12-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hoffmann-La Roche"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05564962",
        "briefTitle": "Quality and Independence of Gait Classification Scale for DMD (QIGS-DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-01-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-10-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-10-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Gait Disorders in Children"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03936894",
        "briefTitle": "Single Escalating Dose Pilot Trial of Canakinumab (ILARIS\u00ae) in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2019-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-05-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's National Research Institute"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05753462",
        "briefTitle": "Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-04-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-03-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sqy Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02858362",
        "briefTitle": "Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2016-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-08-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-01-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Summit Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02470962",
        "briefTitle": "Cardiac Involvement in Patients With Duchenne/Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-06-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-07-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Children's Hospital, Zurich"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne / Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05185622",
        "briefTitle": "A Study to Assess Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-03-21"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-01-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03354039",
        "briefTitle": "Tamoxifen in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-06-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-11-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-12-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Basel, Switzerland"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05135663",
        "briefTitle": "Extension Study of NS-089/NCNP-02 in DMD"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2021-06-23"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-11-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-03-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nippon Shinyaku Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01396239",
        "briefTitle": "Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-07-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-03-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02036463",
        "briefTitle": "A Trial of Chronotherapy of Corticosteroids in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2014-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-01-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-02-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ann & Robert H Lurie Children's Hospital of Chicago"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04821063",
        "briefTitle": "Placebo-Corrected Effects of Therapeutic Dose (100 mg) and Supratherapeutic Dose (300 mg) of ITF2357 (Givinostat) and Moxifloxacin on QT/QTC Interval"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-04-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-03-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne and Becker Muscular Dystrophy",
          "Polycytemia Vera"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06328725",
        "briefTitle": "Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-03-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ENCell"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02194725",
        "briefTitle": "Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-07-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-04-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Human Genome Research Institute (NHGRI)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Stress"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06174025",
        "briefTitle": "Validity and Reliability of the 6 Minute Pegboard Ring Test"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2023-06-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-12-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "\u00c7a\u011ftay Maden"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03507530",
        "briefTitle": "Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2018-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-04-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-04-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Canan \u0130pek"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Neuromuscular Diseases",
          "Duchenne Muscular Dystrophy",
          "Dystrophy",
          "Dystrophy, Muscular"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02147639",
        "briefTitle": "Effects of Sodium Nitrate on Blood Flow in Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-05-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-01-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06013839",
        "briefTitle": "TXA127 in Non-Ambulant Patients With DMD Cardiomyopathy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-08-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Constant Therapeutics LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "DMD-Associated Dilated Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06450639",
        "briefTitle": "An Open-label Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-10-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-06-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hoffmann-La Roche"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06138639",
        "briefTitle": "A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-05-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-11-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Solid Biosciences Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01826422",
        "briefTitle": "Effect of EPA and DHA in the Inflammation and Metabolic Disorders in DMD/DMB Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-03-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Coordinaci\u00f3n de Investigaci\u00f3n en Salud, Mexico"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01834066",
        "briefTitle": "Study Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2014-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-09-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Chaitanya Hospital, Pune"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy",
          "Duchenne Muscular Dystrophy,"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04336826",
        "briefTitle": "A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From \u22656 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-12-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-04-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Nonsene Mutation Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04371666",
        "briefTitle": "Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2020-08-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-05-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "FibroGen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03979157",
        "briefTitle": "Non-invasive Molecular Imaging of Muscle Structure (MSOT_muscles)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-10-14"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-06-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-07-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Erlangen-N\u00fcrnberg Medical School"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02704325",
        "briefTitle": "Gene Transfer Clinical Trial for Duchenne Muscular Dystrophy Using rAAVrh74.MCK.GALGT2"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2016-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-03-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-02-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Kevin Flanigan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02752048",
        "briefTitle": "A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-04-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-04-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Taiho Pharmaceutical Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05280730",
        "briefTitle": "Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-02-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Virginia Commonwealth University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00758225",
        "briefTitle": "Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2008-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-09-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-06-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00428935",
        "briefTitle": "Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2006-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2007-01-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-02-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02165358",
        "briefTitle": "Muscle MRI in Becker Muscular Dystrophy and in Limb-girdle Muscular Dystrophy Type 2I"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-06-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-11-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Rigshospitalet, Denmark"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Limb-Girdle Muscular Dystrophy Type 2I"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01239758",
        "briefTitle": "Extension Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2010-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-11-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-02-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03238235",
        "briefTitle": "Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-12-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-08-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-01-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03558958",
        "briefTitle": "Safety and Efficacy of P-188 NF in DMD Patients"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-08-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-06-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-01-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Phrixus Pharmaceuticals, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05019625",
        "briefTitle": "Biomarker Development for Muscular Dystrophies"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2015-02-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-08-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Massachusetts General Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Myotonic Dystrophy",
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Facioscapulohumeral Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01478022",
        "briefTitle": "To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-11-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-08-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Parent Project, Italy"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00799266",
        "briefTitle": "An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2008-12-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-11-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-09-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Novartis Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Osteoporosis"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02081625",
        "briefTitle": "Exploratory Study of NS-065/NCNP-01 in DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-03-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-02-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Center of Neurology and Psychiatry, Japan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05670730",
        "briefTitle": "Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2022-11-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Avidity Biosciences, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Exon 44"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05126758",
        "briefTitle": "A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-06-22"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-11-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Capricor Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Muscular Dystrophy, Duchenne",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Neuromuscular Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn",
          "Nervous System Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06124196",
        "briefTitle": "Wearable Technology to Evaluate Hyperglycemia and HRV in DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-03-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-11-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Vanderbilt University Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06540365",
        "briefTitle": "Applying the Pathways and Resources for Engagement and Participation Protocol Among People With Muscles Dystrophies"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Haifa"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04004065",
        "briefTitle": "Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Efficacy (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2019-06-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-07-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01978366",
        "briefTitle": "Open Label Extension Study of HT-100 in Patients With DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-11-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-09-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Processa Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01506518",
        "briefTitle": "Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-01-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-08-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of North Carolina, Chapel Hill"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06290713",
        "briefTitle": "Vasodilator and Exercise Study for DMD (VASO-REx)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-06-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-03-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Duchenne Disease",
          "Muscular Dystrophy",
          "Muscular Dystrophy in Children",
          "Vasodilation",
          "Exercise",
          "DMD"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04173234",
        "briefTitle": "Aerobic Exercise in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-04-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-11-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-09-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01385917",
        "briefTitle": "Observational Study of Patients With Duchenne Muscular Dystrophy Theoretically Treatable With Exon 53 Skipping"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2011-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-06-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-04-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Genethon"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01648634",
        "briefTitle": "Nebivolol for the Prevention of Left Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-02-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-07-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-09-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Cardiomyopathy",
          "Heart Failure"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00893334",
        "briefTitle": "Evaluation of Limb-Girdle Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-05-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-03-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Limb-Girdle Muscular Dystrophy, Type 2A (Calpain-3 Deficiency)",
          "Limb-Girdle Muscular Dystrophy, Type 2B (Miyoshi Myopathy, Dysferlin Deficiency)",
          "Limb-Girdle Muscular Dystrophy, Type 2I (FKRP-deficiency)"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04386304",
        "briefTitle": "Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-07-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-05-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Epirium Bio Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03513367",
        "briefTitle": "The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM."
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2018-09-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-04-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Toulouse"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01540604",
        "briefTitle": "CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "studyFirstPostDateStruct": {
          "date": "2012-02-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2012-10-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "RSPR Pharma AB"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02329769",
        "briefTitle": "Open Label, Extension Study of PRO044 in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2014-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-01-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00004646",
        "briefTitle": "Phase III Randomized, Double-Blind Study of Prednisone for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "1995-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2000-02-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2005-06-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Center for Research Resources (NCRR)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06337669",
        "briefTitle": "Characterization of DupEx2 Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-01-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-03-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "IRCCS San Raffaele"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00110669",
        "briefTitle": "High-dose Prednisone in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2004-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-05-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04768062",
        "briefTitle": "Study to Assess the Safety and Efficacy of Viltolarsen in Ambulant Boys With DMD (RACER53-X)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2021-04-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-02-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02500381",
        "briefTitle": "Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2016-09-28"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-07-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05436210",
        "briefTitle": "Postural and Anthropometric Properties of Foot and Ankle of Patients With DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-06-23"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-06-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-01-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Ambulation Difficulty",
          "Posture Disorders in Children",
          "Ambulation Disorder, Neurologic"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02235844",
        "briefTitle": "Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-09-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-09-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Allergy and Asthma Consultants, Wichita, Kansas"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne's Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01081080",
        "briefTitle": "Cardiac Magnetic Resonance in Children With Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-03-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-01-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Limb Girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02972580",
        "briefTitle": "Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2016-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-11-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06066580",
        "briefTitle": "Open-Label Extension of EDG-5506 in Participants with Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2023-11-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03760029",
        "briefTitle": "A Natural History Study In Chinese Male Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-07-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-11-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00390104",
        "briefTitle": "Molecular Analysis of Patients With Neuromuscular Disease"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2002-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2006-10-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-04-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Boston Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Neuromuscular; Disorder, Hereditary",
          "Duchenne/Becker Muscular Dystrophy",
          "Limb-girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01954940",
        "briefTitle": "Whole Body Vibration Therapy in Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-10-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-08-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital of Eastern Ontario"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06053814",
        "briefTitle": "NS-050/NCNP-03 in Boys With DMD (Meteor50)"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-09-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06186310",
        "briefTitle": "Effectiveness of Aquatic Therapy in Children With Duchenne and Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2023-11-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-01-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Gaziosmanpasa Research and Education Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne or Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06539169",
        "briefTitle": "FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-06-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "xCures"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Alpha-Thalassemia",
          "Beta-Thalassemia",
          "Amyloidosis",
          "Amyotrophic Lateral Sclerosis",
          "Creutzfeld-Jakob Disease",
          "Cystic Fibrosis",
          "Duchenne Muscular Dystrophy",
          "Early-Onset Alzheimer Disease",
          "Ehlers-Danlos Syndrome",
          "Huntington Disease",
          "Gaucher Disease",
          "GM1 Gangliosidosis",
          "Myasthenia Gravis",
          "Pompe Disease",
          "Sickle Cell Disease",
          "Transthyretin Amyloid Cardiomyopathy",
          "Rare Diseases"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02196467",
        "briefTitle": "Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2014-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-07-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-01-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "CHU de Quebec-Universite Laval"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01098708",
        "briefTitle": "This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-04-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-01-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Washington University School of Medicine"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04587908",
        "briefTitle": "A Phase 3 Study of TAS-205 in Patients With Duchenne Muscular Dystrophy\uff08REACH-DMD\uff09"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-11-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-10-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Taiho Pharmaceutical Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06241950",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2024-01-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-02-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00159250",
        "briefTitle": "Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2007-10-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-09-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-12-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Imperial College London"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04120168",
        "briefTitle": "Study Determining the Frequency of Duchenne Muscular Dystrophy and Late-onset Pompe Disease"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-04-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-10-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-10-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Turkish Society of Pediatric Gastroenterology, Hepatology and Nutrition"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Pompe Disease (Late-onset)"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01580501",
        "briefTitle": "PDE Inhibitors in DMD Study (Acute Dosing Study)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-04-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-01-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02907619",
        "briefTitle": "An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2016-10-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-09-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-11-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06574919",
        "briefTitle": "Clinical and Functional Assessment of Patients With Inherited Non-Duchenne Myopathies in Sohag University Hospital"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-08-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sohag University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Inherited Non-Duchenne Myopathies"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02814019",
        "briefTitle": "A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2016-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-06-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04668716",
        "briefTitle": "Brain Involvement in Dystrophinopathies Part 2"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-10-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-12-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02241434",
        "briefTitle": "Stem Cell Therapy in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2009-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-09-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-10-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Neurogen Brain and Spine Institute"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06392724",
        "briefTitle": "A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Peking Union Medical College Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04433234",
        "briefTitle": "Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-06-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-06-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Daiichi Sankyo Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04607824",
        "briefTitle": "Heart Rate Variability in Duchenne Muscular Dystrophy During Computer Task"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-10-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-10-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Sao Paulo"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03127241",
        "briefTitle": "User-centred Assistive System for Arm Functions in Neuromuscular Subjects"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-06-16"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-04-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-12-10"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Politecnico di Milano"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophy, Becker",
          "Muscular Dystrophy, Limb-Girdle Type 2"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02167217",
        "briefTitle": "Historically Controlled Trial of Corticosteroids in Young Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-04-17"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-06-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-12-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Washington University School of Medicine"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03789734",
        "briefTitle": "Safety Study of BLS-M22 in Healthy Volunteers"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-06-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-12-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-04-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioLeaders Corporation"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03777319",
        "briefTitle": "Spironolactone Versus Prednisolone in DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-12-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-12-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Kevin Flanigan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06295718",
        "briefTitle": "Tele-assessment of Functional Performance and Quality of Life in Patients With Duchenne Muscular Dystrophy: Validity and Reliability Study"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2023-07-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-03-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sahra \u015eirvan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04583917",
        "briefTitle": "Brain Involvement in Dystrophinopathies Part 1"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-03-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-10-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Great Ormond Street Hospital for Children NHS Foundation Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05982119",
        "briefTitle": "Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLi\u00e8ge Next Study"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2020-07-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Laurent Servais"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Fascioscapulohumeral Muscular Dystrophy",
          "Myotonic Dystrophy 1",
          "Charcot-Marie-Tooth",
          "Centronuclear Myopathy",
          "Congenital Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01254019",
        "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-12-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-12-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-01-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02592941",
        "briefTitle": "Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "APPROVED_FOR_MARKETING",
        "studyFirstPostDateStruct": {
          "date": "2015-10-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-02-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03863119",
        "briefTitle": "Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "AVAILABLE",
        "studyFirstPostDateStruct": {
          "date": "2019-03-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06270719",
        "briefTitle": "An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-02-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-02-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03917719",
        "briefTitle": "An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2019-03-14"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-04-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-11-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catabasis Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01910649",
        "briefTitle": "A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2008-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-07-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-11-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02376816",
        "briefTitle": "Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-03-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-11-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Jerry R. Mendell"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01890616",
        "briefTitle": "Constipation and Gut Transit in DMD Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-07-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-09-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital Medical Center, Cincinnati"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Constipation",
          "DMD"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03769116",
        "briefTitle": "A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-12-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-12-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01182324",
        "briefTitle": "The PTC124 (Ataluren) Clinical Trial for Duchenne Muscular Dystrophy: Exploration of the Experiences of Parents, Clinician Researchers, and the Industry Sponsor"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-07-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-08-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-04-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Human Genome Research Institute (NHGRI)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02161835",
        "briefTitle": "Relations Between Myotonia and Fitness"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-06-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Grete Andersen, MD"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Congenital Myotonia"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05601986",
        "briefTitle": "Motor Imagery on Children With DMD on Gait and Balance Functions"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-12-16"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-11-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "G\u00fclsena Utku"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02606136",
        "briefTitle": "Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2016-01-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-11-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "FibroGen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05558813",
        "briefTitle": "Natural History of Duchenne Muscular Dystrophy Cardiomyopathy (DMD-CMP)"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-09-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03786913",
        "briefTitle": "Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-03-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-12-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-02-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Benha University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Inflammatory Myopathy",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00308113",
        "briefTitle": "CoQ10 and Prednisone in Non-Ambulatory DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2007-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2006-03-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-11-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03534349",
        "briefTitle": "Lower Limb Flexibility in Duchenne Muscular Dystrophy: Effects on Functional Performance"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Performance",
          "Flexibility"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03541070",
        "briefTitle": "The Effect of Kinesiology Taping on Balance in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-06-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Balance",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01957059",
        "briefTitle": "A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-10-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03340675",
        "briefTitle": "Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2020-10-19"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-11-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cumberland Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy Cardiomyopathy",
          "Cardiomyopathy, Dilated"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04054375",
        "briefTitle": "Weekly Steroids in Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-07-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-08-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Northwestern University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Limb-girdle Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02090959",
        "briefTitle": "An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2014-03-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-03-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-08-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophies",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Musculoskeletal Diseases",
          "Neuromuscular Diseases",
          "Nervous System Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03947112",
        "briefTitle": "Physical Activity Level of Norwegian Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-08-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-05-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Haukeland University Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01803412",
        "briefTitle": "A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-03-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-06-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03218995",
        "briefTitle": "Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-08-16"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-07-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05330195",
        "briefTitle": "Bicycle Ergometer Training in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-04-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-04-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01982695",
        "briefTitle": "Cardiomyopathy in DMD: Lisinopril vs. Losartan"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-11-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-03-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)",
          "Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01451281",
        "briefTitle": "Studying Skeletal Muscle, Heart, and Diaphragm Imaging in Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-09-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-10-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-05-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Institute of Neurological Disorders and Stroke (NINDS)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy",
          "Muscular Disease"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03655223",
        "briefTitle": "Early Check: Expanded Screening in Newborns"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2018-10-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-08-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "RTI International"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Spinal Muscular Atrophy",
          "Fragile X Syndrome",
          "Fragile X - Premutation",
          "Duchenne Muscular Dystrophy",
          "Hyperinsulinemic Hypoglycemia, Familial 1",
          "Diabetes Mellitus",
          "Adrenoleukodystrophy, Neonatal",
          "Medium-chain Acyl-CoA Dehydrogenase Deficiency",
          "Very Long Chain Acyl Coa Dehydrogenase Deficiency",
          "Beta-ketothiolase Deficiency",
          "Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency",
          "Primary Hyperoxaluria Type 1",
          "Congenital Bile Acid Synthesis Defect Type 2",
          "Pyridoxine-Dependent Epilepsy",
          "Hereditary Fructose Intolerance",
          "Hypophosphatasia",
          "Hyperargininemia",
          "Mucopolysaccharidosis Type 6",
          "Argininosuccinic Aciduria",
          "Citrullinemia, Type I",
          "Wilson Disease",
          "Maple Syrup Urine Disease, Type 1A",
          "Maple Syrup Urine Disease, Type 1B",
          "Biotinidase Deficiency",
          "Neonatal Severe Primary Hyperparathyroidism",
          "Intrinsic Factor Deficiency",
          "Usher Syndrome Type 1D/F Digenic (Diagnosis)",
          "Cystic Fibrosis",
          "Stickler Syndrome Type 2",
          "Stickler Syndrome Type 1",
          "Alport Syndrome, Autosomal Recessive",
          "Alport Syndrome, X-Linked",
          "Carbamoyl Phosphate Synthetase I Deficiency Disease",
          "Carnitine Palmitoyl Transferase 1A Deficiency",
          "Carnitine Palmitoyltransferase II Deficiency",
          "Cystinosis",
          "Chronic Granulomatous Disease",
          "Cerebrotendinous Xanthomatoses",
          "Maple Syrup Urine Disease, Type 2",
          "Severe Combined Immunodeficiency Due to DCLRE1C Deficiency",
          "Thyroid Dyshormonogenesis 6",
          "Thyroid Dyshormonogenesis 5",
          "Supravalvar Aortic Stenosis",
          "Factor X Deficiency",
          "Hemophilia A",
          "Hemophilia B",
          "Tyrosinemia, Type I",
          "Fructose 1,6 Bisphosphatase Deficiency",
          "Glycogen Storage Disease Type I",
          "G6PD Deficiency",
          "Glycogen Storage Disease II",
          "Galactokinase Deficiency",
          "Mucopolysaccharidosis Type IV A",
          "Galactosemias",
          "Guanidinoacetate Methyltransferase Deficiency",
          "Agat Deficiency",
          "Glutaryl-CoA Dehydrogenase Deficiency",
          "Gtp Cyclohydrolase I Deficiency",
          "Hyperinsulinism-Hyperammonemia Syndrome",
          "Primary Hyperoxaluria Type 2",
          "3-Hydroxyacyl-CoA Dehydrogenase Deficiency",
          "Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency",
          "Mitochondrial Trifunctional Protein Deficiency",
          "Sickle Cell Disease",
          "Beta-Thalassemia",
          "Holocarboxylase Synthetase Deficiency",
          "3-Hydroxy-3-Methylglutaric Aciduria",
          "Primary Hyperoxaluria Type 3",
          "Hermansky-Pudlak Syndrome 1",
          "Hermansky-Pudlak Syndrome 4",
          "Apparent Mineralocorticoid Excess",
          "HSDB",
          "CBAS1",
          "Mucopolysaccharidosis Type 2",
          "Mucopolysaccharidosis Type 1",
          "Severe Combined Immunodeficiency, X Linked",
          "Severe Combined Immunodeficiency Due to IL-7Ralpha Deficiency",
          "Diabetes Mellitus, Permanent Neonatal",
          "Isovaleric Acidemia",
          "Severe Combined Immunodeficiency T-Cell Negative B-Cell Positive Due to Janus Kinase-3 Deficiency (Disorder)",
          "Jervell and Lange-Nielsen Syndrome 2",
          "Hyperinsulinemic Hypoglycemia, Familial, 2",
          "Diabetes Mellitus, Permanent Neonatal, With Neurologic Features",
          "Jervell and Lange-Nielsen Syndrome 1",
          "Lysosomal Acid Lipase Deficiency",
          "CblF",
          "3-Methylcrotonyl CoA Carboxylase 1 Deficiency",
          "3-Methylcrotonyl CoA Carboxylase 2 Deficiency",
          "Waardenburg Syndrome Type 2A",
          "Methylmalonic Aciduria cblA Type",
          "Methylmalonic Aciduria cblB Type",
          "Methylmalonic Aciduria and Homocystinuria Type cblC",
          "MAHCD",
          "Methylmalonic Aciduria Due to Methylmalonyl-CoA Mutase Deficiency",
          "Congenital Disorder of Glycosylation Type 1B",
          "Mthfr Deficiency",
          "Methylcobalamin Deficiency Type Cbl G (Disorder)",
          "Methylcobalamin Deficiency Type cblE",
          "Usher Syndrome, Type 1B",
          "N-acetylglutamate Synthase Deficiency",
          "Ornithine Transcarbamylase Deficiency",
          "Phenylketonurias",
          "Waardenburg Syndrome Type 1",
          "Congenital Hypothyroidism",
          "Propionic Acidemia",
          "Usher Syndrome, Type 1F",
          "Pancreatic Agenesis 1",
          "Hereditary Hypophosphatemic Rickets",
          "Glycogen Storage Disease IXB",
          "Glycogen Storage Disease IXC",
          "MOWS",
          "Epilepsy, Early-Onset, Vitamin B6-Dependent",
          "Pyridoxal Phosphate-Responsive Seizures",
          "Pituitary Hormone Deficiency, Combined, 1",
          "Ptsd",
          "Dihydropteridine Reductase Deficiency",
          "Severe Combined Immunodeficiency Due to RAG1 Deficiency",
          "Severe Combined Immunodeficiency Due to RAG2 Deficiency",
          "Retinoblastoma",
          "Multiple Endocrine Neoplasia Type 2B",
          "Pseudohypoaldosteronism, Type I",
          "Liddle Syndrome",
          "Biotin-Responsive Basal Ganglia Disease",
          "SCD",
          "DIAR1",
          "GSD1C",
          "Acrodermatitis Enteropathica",
          "Thyroid Dyshormonogenesis 1",
          "Riboflavin Transporter Deficiency",
          "Waardenburg Syndrome, Type 2E",
          "SRD",
          "Congenital Lipoid Adrenal Hyperplasia Due to STAR Deficiency",
          "Barth Syndrome",
          "Adrenocorticotropic Hormone Deficiency",
          "Transcobalamin II Deficiency",
          "Thyroid Dyshormonogenesis 3",
          "Segawa Syndrome, Autosomal Recessive",
          "Autosomal Recessive Nonsyndromic Hearing Loss",
          "Thyroid Dyshormonogenesis 2A",
          "Congenital Isolated Thyroid Stimulating Hormone Deficiency",
          "Hypothyroidism Due to TSH Receptor Mutations",
          "Usher Syndrome Type 1C",
          "Usher Syndrome Type 1G (Diagnosis)",
          "Von Willebrand Disease, Type 3",
          "Combined Immunodeficiency Due to ZAP70 Deficiency",
          "Adenine Phosphoribosyltransferase Deficiency",
          "Metachromatic Leukodystrophy",
          "Canavan Disease",
          "Menkes Disease",
          "Carbonic Anhydrase VA Deficiency",
          "Developmental and Epileptic Encephalopathy 2",
          "17 Alpha-Hydroxylase Deficiency",
          "Smith-Lemli-Opitz Syndrome",
          "Krabbe Disease",
          "Glutathione Synthetase Deficiency",
          "Mucopolysaccharidosis Type 7",
          "Rett Syndrome",
          "Molybdenum Cofactor Deficiency, Type A",
          "Niemann-Pick Disease, Type C1",
          "Niemann-Pick Disease Type C2",
          "Ornithine Aminotransferase Deficiency",
          "3-Phosphoglycerate Dehydrogenase Deficiency",
          "Leber Congenital Amaurosis 2",
          "Dravet Syndrome",
          "Mucopolysaccharidosis Type 3 A",
          "Ornithine Translocase Deficiency",
          "Carnitine-acylcarnitine Translocase Deficiency",
          "Glucose Transporter Type 1 Deficiency Syndrome",
          "Creatine Transporter Deficiency",
          "Niemann-Pick Disease Type A",
          "Pitt Hopkins Syndrome",
          "Tuberous Sclerosis 1",
          "Tuberous Sclerosis 2",
          "Ataxia With Isolated Vitamin E Deficiency",
          "Angelman Syndrome",
          "Prader-Willi Syndrome",
          "Homocystinuria",
          "Permanent Neonatal Diabetes Mellitus",
          "Transient Neonatal Diabetes Mellitus",
          "Factor VII Deficiency",
          "Glycogen Storage Disease Type IXA1",
          "Glycogen Storage Disease, Type IXA2",
          "Glycogen Storage Disease IC",
          "Glycogen Storage Disease Type IB",
          "Central Hypoventilation Syndrome With or Without Hirschsprung Disease"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02413450",
        "briefTitle": "Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2013-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-04-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Johns Hopkins University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Inherited Cardiac Arrythmias",
          "Long QT Syndrome (LQTS)",
          "Brugada Syndrome (BrS)",
          "Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)",
          "Early Repolarization Syndrome (ERS)",
          "Arrhythmogenic Cardiomyopathy (AC, ARVD/C)",
          "Hypertrophic Cardiomyopathy (HCM)",
          "Dilated Cardiomyopathy (DCM)",
          "Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)",
          "Normal Control Subjects"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05990608",
        "briefTitle": "Peabody Developmental Motor Scaling In Children With Period Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-07-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-08-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ondokuz May\u0131s University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06643923",
        "briefTitle": "Effects of Lumbopelvic Stabilization-based Physiotherapy and Rehabilitation Training in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-12-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-10-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Lokman Hekim \u00dcniversitesi"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)",
          "Lower Urinary Track Symptoms"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05881408",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-05-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-05-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02421523",
        "briefTitle": "Strength Training in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-05-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-04-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-03-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01335295",
        "briefTitle": "Safety Study of Flavocoxid in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-04-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-02-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Messina"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05313295",
        "briefTitle": "Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-11-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-04-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-05-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Universidad de Almeria"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Neurologic Disorder",
          "Duchenne",
          "Pediatric Disorder",
          "Sensorimotor Disorder Nos"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02354781",
        "briefTitle": "Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-02-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Jerry R. Mendell"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05559710",
        "briefTitle": "Motor Imagery in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-06-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-09-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-12-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04708314",
        "briefTitle": "An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2020-10-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-01-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-05-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Rare Disease Research, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04240314",
        "briefTitle": "AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications."
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-01-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-01-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-02-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Megan Waldrop"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03589612",
        "briefTitle": "Regression of Hamstring Flexibility and Performance in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-03-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-07-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-09-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Performance",
          "Flexibility"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01000012",
        "briefTitle": "Compassionate Use of the Becker Expander/Breast Implant"
      },
      "statusModule": {
        "overallStatus": "NO_LONGER_AVAILABLE",
        "studyFirstPostDateStruct": {
          "date": "2009-10-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-10-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mentor Worldwide, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Breast Reconstruction"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04337112",
        "briefTitle": "The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation"
      },
      "statusModule": {
        "overallStatus": "APPROVED_FOR_MARKETING",
        "studyFirstPostDateStruct": {
          "date": "2020-04-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-08-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "DMD"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03779646",
        "briefTitle": "Bisoprolol in DMD Early Cardiomyopathy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2019-01-16"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-12-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Peking Union Medical College Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Cardiomyopathy, Dilated"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06641895",
        "briefTitle": "Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-07-25"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-10-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Shanghai Jiao Tong University School of Medicine"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05244395",
        "briefTitle": "Development of a New Instrument to Evaluate Gait Characteristics of Individuals With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-02-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-02-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-03-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Gait Disorders in Children",
          "Gait Disorders, Neurologic"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01521546",
        "briefTitle": "Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-01-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-11-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Subha Raman"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02515669",
        "briefTitle": "Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2015-12-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-08-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-11-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hoffmann-La Roche"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01856868",
        "briefTitle": "Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-05-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Craig McDonald, MD"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01168908",
        "briefTitle": "Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2010-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-07-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-02-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hugo W. Moser Research Institute at Kennedy Krieger, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05938023",
        "briefTitle": "A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2023-05-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-07-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Percheron Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02056808",
        "briefTitle": "A Phase 1b Study of SMT C1100 in Subjects With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-02-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-08-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Summit Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02168114",
        "briefTitle": "Magnetic Resonance and Optical Imaging of Dystrophic and Damaged Muscle"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-06-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-01-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03490214",
        "briefTitle": "Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-06-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-04-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-12-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Erlangen-N\u00fcrnberg Medical School"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Muscular Dystrophies",
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06147414",
        "briefTitle": "Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-11-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, Including",
          "Sickle Cell Disease",
          "Cystic Fibrosis",
          "Fragile X Syndrome",
          "Proximal Spinal Muscular Atrophy",
          "Myotonic Dystrophy",
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophy, Becker",
          "Neurofibromatosis-Noonan Syndrome",
          "Huntington Disease",
          "Hemophilia A",
          "Hemophilia B",
          "MODY2 Diabetes",
          "X-Linked Hydrocephalus",
          "Autosomal Recessive Polycystic Kidney Disease"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05657938",
        "briefTitle": "Evaluation of Home Based Assessments on Participants With DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-10-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-12-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-08-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Solid Biosciences Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06565208",
        "briefTitle": "First in Human SAD/MAD Safety and PK Study With Adult DMD Safety and PK Cohort"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-08-21"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Satellos Bioscience, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01207908",
        "briefTitle": "Safety and Efficacy Study of IGF-1 in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-09-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-01-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital Medical Center, Cincinnati"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05016908",
        "briefTitle": "Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2019-11-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-08-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Massachusetts General Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05274555",
        "briefTitle": "Reliability and Validity of the Turkish Version of the Upper Limb Short Questionnaire in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-03-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-03-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-06-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Dokuz Eylul University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Upper Extremity Problem"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03167255",
        "briefTitle": "Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-07-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-05-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-12-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01128855",
        "briefTitle": "A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-07-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-05-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-07-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01491555",
        "briefTitle": "Electrical Impedance Myography and Ultrasound as Biomarkers of Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-12-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-03-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Boston Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03375255",
        "briefTitle": "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 (Vesleteplirsen) in Patients With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-02-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-07-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03372655",
        "briefTitle": "Prognostic Factors Affecting Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2018-01-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-12-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assiut University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01066455",
        "briefTitle": "Cardiac Outcome Measures in Children With Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-02-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-01-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Limb Girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02834650",
        "briefTitle": "Validating Cardiac MRI Biomarkers and Genotype-Phenotype Correlations for DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-02-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-07-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-05-10"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Stanford University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02835079",
        "briefTitle": "Treatment Effect of Tamoxifen on Patients With DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-07-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-07-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hadassah Medical Organization"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02340923",
        "briefTitle": "A Device for Rapid, Painless, Bedside Muscle Evaluation of Children"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-01-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-08-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Skulpt, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05409079",
        "briefTitle": "Schulze Muscular Dystrophy Ability Clinical Study"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-05-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-06-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-12-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "AbiliTech Medical Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies",
          "Spinal Muscular Atrophy",
          "Duchenne Muscular Dystrophy",
          "Limb Girdle Muscular Dystrophy",
          "FSHD",
          "Cerebral Palsy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02891434",
        "briefTitle": "Analysis of a Virtual Reality Task in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-09-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-04-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Sao Paulo"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00033813",
        "briefTitle": "KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2002-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2002-04-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-03-10"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06079736",
        "briefTitle": "A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-01-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PepGen Inc"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04060199",
        "briefTitle": "Study to Assess the Efficacy and Safety of Viltolarsen in Ambulant Boys With DMD (RACER53)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-04-14"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-08-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05549999",
        "briefTitle": "Cultural Adaptation, Validity, and Reliability of the Turkish Version of North Star Ambulatory Assessment"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-11-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-09-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-07-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Ambulation Difficulty",
          "Ambulation Disorder, Neurologic"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05338099",
        "briefTitle": "Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2022-01-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-04-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ENCell"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02195999",
        "briefTitle": "Assessment of Cardiopulmonary Function in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-07-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-07-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03038399",
        "briefTitle": "Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-02-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-01-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-05-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ReveraGen BioPharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03532542",
        "briefTitle": "An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-08-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02310906",
        "briefTitle": "Phase I/II Study of SRP-4053 in DMD Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-01-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-12-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-10-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01286870",
        "briefTitle": "Becker Continued Access Study"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2009-06-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-01-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-03-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mentor Worldwide, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Breast Reconstruction"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05195775",
        "briefTitle": "Tadalafil as Adjuvant Therapy for DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-12-14"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-01-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03951675",
        "briefTitle": "The Burden of Access in Duchenne Muscular Dystrophy in the US"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-06-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-05-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-08-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01359670",
        "briefTitle": "Tadalafil and Sildenafil for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-05-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-01-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04335942",
        "briefTitle": "Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-09-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-04-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-08-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Spinal Muscular Atrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06402942",
        "briefTitle": "Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-09-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-05-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ba\u015fak \u00c7a\u011fla Arslan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Gamification",
          "Occupational Therapy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01519349",
        "briefTitle": "Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-01-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Sporadic Inclusion Body Myositis"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02789059",
        "briefTitle": "Muscle Oxygenation in Effort in Neuromuscular Diseases"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-07-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-06-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-05-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Lille"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Neuromuscular Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06379906",
        "briefTitle": "Upper Extremity Muscle Strength, Balance and Functional Skills in DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2023-11-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Halic University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06103006",
        "briefTitle": "Remote Physiotherapy to Protect Physical Health in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-01-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Lokman Hekim \u00dcniversitesi"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01557400",
        "briefTitle": "Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-05-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-03-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-11-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Dystrophinopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06579859",
        "briefTitle": "Development of a Registry to Assess Natural History in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2024-11-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-08-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06579352",
        "briefTitle": "Expanded Access Study of UC-MSC in DMD Patients"
      },
      "statusModule": {
        "overallStatus": "AVAILABLE",
        "studyFirstPostDateStruct": {
          "date": "2024-08-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "MED Institute Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01712152",
        "briefTitle": "Myocardial Involvement in Carriers of Duchenne Muscular Dystrophy: An MRI-study"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-10-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-10-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hospital Rudolfstiftung"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Carrier of Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00468832",
        "briefTitle": "Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2005-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2007-05-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-04-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01995032",
        "briefTitle": "L-citrulline and Metformin in Duchenne's Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-11-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-04-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Basel, Switzerland"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne's Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05029232",
        "briefTitle": "Comprehensive Study of Duchenne Muscular Dystrophy at Sohag University Hospital"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2021-10-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-08-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-08-31"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sohag University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01422200",
        "briefTitle": "Flu Vaccine Study in Neuromuscular Patients 2011"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-08-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-10-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital Medical Center, Cincinnati"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Spinal Muscular Atrophy",
          "Congenital Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02354352",
        "briefTitle": "Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-03-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-02-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-10-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ohio State University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01197300",
        "briefTitle": "1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-10-25"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-09-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-09-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Novartis Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Osteoporosis"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03836300",
        "briefTitle": "Parent and Infant Inter(X)Action Intervention (PIXI)"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2018-11-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-02-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "RTI International"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Fragile X Syndrome",
          "Angelman Syndrome",
          "Prader-Willi Syndrome",
          "Dup15Q Syndrome",
          "Duchenne Muscular Dystrophy",
          "Phelan-McDermid Syndrome",
          "Rett Syndrome",
          "Smith Magenis Syndrome",
          "Williams Syndrome",
          "Turner Syndrome",
          "Klinefelter Syndrome",
          "Chromosome 22q11.2 Deletion Syndrome",
          "Tuberous Sclerosis",
          "Down Syndrome"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01386515",
        "briefTitle": "The Role of Family Functioning in Promoting Adaptation in Siblings of Individuals With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2011-06-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-07-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-12-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Human Genome Research Institute (NHGRI)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Genetic Disease",
          "Communication"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04193085",
        "briefTitle": "Wearable Technology to Assess Gait Function in SMA and DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-11-25"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-12-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Columbia University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Spinal Muscular Atrophy Type 3",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05110885",
        "briefTitle": "Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2021-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-11-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-11-10"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Bah\u00e7e\u015fehir University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Spinal Muscular Atrophy",
          "Duchenne Muscular Dystrophy",
          "Healthy Individuals"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04281485",
        "briefTitle": "Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2020-11-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-02-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05160415",
        "briefTitle": "A Study of EDG-5506 in Adult Males With Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-12-28"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-12-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06445985",
        "briefTitle": "Hydrotherapy in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-11-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-06-06"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Lancashire Teaching Hospitals NHS Foundation Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03443115",
        "briefTitle": "Duchenne Muscular Dystrophy Heart Study"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2017-06-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-02-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-02-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "H\u00f4pital Cochin"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Duchenne Muscular Dystrophy-Associated Dilated Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02516085",
        "briefTitle": "Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-08-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-08-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Basel, Switzerland"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02432885",
        "briefTitle": "Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-05-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "InCor Heart Institute"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Myocardial Fibrosis",
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01037309",
        "briefTitle": "Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-12-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03400852",
        "briefTitle": "A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-07-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-01-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-03-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mallinckrodt ARD LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06093100",
        "briefTitle": "Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-07-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Vanderbilt University Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00750685",
        "briefTitle": "Study of the Mentor Becker Expander/Breast Implant in Subjects Who Are Undergoing Primary Breast Reconstruction"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2007-03-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-09-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mentor Worldwide, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Breast Reconstruction"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01981915",
        "briefTitle": "Optimum Insufflation Capacity in NMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-11-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-11-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Universit\u00e4t Duisburg-Essen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Spinal Muscular Atrophy",
          "Chronic Respiratory Insufficiency"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06366815",
        "briefTitle": "phenotypeS in Non Ambulant Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-08-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-04-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Natural History",
          "Motor Function; Retardation"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02255552",
        "briefTitle": "Study of Eteplirsen in DMD Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-11-17"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-10-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-01-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02251600",
        "briefTitle": "A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-09-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-08-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05693142",
        "briefTitle": "AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-01-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "REGENXBIO Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06643442",
        "briefTitle": "Repurposing Empagliflozin for DMD-associated Cardiomyopathy in Children 6-18 Years of Age"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2025-02-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-10-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sebastiano Lava"
        }
      },
      "conditionsModule": {
        "conditions": [
          "DMD-associated Dilated Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05514249",
        "briefTitle": "Treatment of a Single Patient With CRD-TMH-001"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2022-08-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-08-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cure Rare Disease, Inc"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03368742",
        "briefTitle": "Microdystrophin Gene Transfer Study in Adolescents and Children With DMD"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2017-12-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Solid Biosciences Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01153932",
        "briefTitle": "Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-06-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-08-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03057002",
        "briefTitle": "UTSW HP [13-C] Pyruvate Injection in HCM"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2018-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-02-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Texas Southwestern Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Cardiomyopathy, Hypertrophic",
          "Dilated Cardiomyopathy",
          "Duchenne Muscular Dystrophy",
          "Cardiac Sarcoidosis",
          "Becker Muscular Dystrophy",
          "Heart Failure With Preserved Ejection Fraction",
          "Heart Failure With Reduced Ejection Fraction"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01865084",
        "briefTitle": "A Study of Tadalafil for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2013-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-05-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-10-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Eli Lilly and Company"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03335384",
        "briefTitle": "Relationship Between PFTs and Pdi in DMD"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2018-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-11-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Minnesota"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01027884",
        "briefTitle": "Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-12-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-10-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Ambulatory Care"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02420379",
        "briefTitle": "Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-06-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-04-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-01-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03362502",
        "briefTitle": "A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2018-01-23"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02958202",
        "briefTitle": "Extension Study of BMN 044 in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2016-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-11-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-01-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01523964",
        "briefTitle": "DART Electrical Impedance Myography (EIM) Trial in Duchenne Muscular Dystrophy (DMD) and Healthy Controls"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-02-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-12-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Dart Therapeutics. LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01388764",
        "briefTitle": "Safety, Tolerability and Effects of L-Arginine in Boys With Dystrophinopathy on Corticosteroids"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-07-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2012-07-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Massachusetts General Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Dystrophinopathy",
          "Duchenne Muscular Dystrophy",
          "Becker's Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05689164",
        "briefTitle": "A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular Dystrophy."
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-03-13"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02472990",
        "briefTitle": "Biomechanical and Morphological Changes in Dystrophic Muscle"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2015-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-06-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-03-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Brest"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Dystrophy Muscular"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01380964",
        "briefTitle": "Research of Biomarkers in Duchenne Muscular Dystrophy Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-06-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-08-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Genethon"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06128564",
        "briefTitle": "A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-11-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-11-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hoffmann-La Roche"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00674843",
        "briefTitle": "The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2008-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-05-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2009-08-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GAAD Medical Research Institute Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04585464",
        "briefTitle": "A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-10-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-10-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-06-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Healthy Volunteer",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06304064",
        "briefTitle": "Halt cardiomyOPathy progrEssion in Duchenne (HOPE-OLE)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-06-21"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-03-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-04-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Capricor Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00296621",
        "briefTitle": "Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2006-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2006-02-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2007-12-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03375164",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-01-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-12-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02525302",
        "briefTitle": "HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2015-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-08-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-03-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Akashi Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05096221",
        "briefTitle": "A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2021-10-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-10-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01918384",
        "briefTitle": "Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2013-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-08-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-09-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Kobe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02485938",
        "briefTitle": "HOPE-Duchenne (Halt cardiomyOPathy progrEssion in Duchenne)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-06-30"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-07-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Capricor Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Cardiomyopathy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03333590",
        "briefTitle": "Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2017-11-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2017-11-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Kevin Flanigan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02760264",
        "briefTitle": "A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-05-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-01-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ReveraGen BioPharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05996003",
        "briefTitle": "NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-02-22"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "NS Pharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00847379",
        "briefTitle": "Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2009-01-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-02-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-07-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05683379",
        "briefTitle": "AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys With DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-12-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-01-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "REGENXBIO Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00654784",
        "briefTitle": "Efficacy and Tolerability of Idebenone in Boys With Cardiac Dysfunction Associated With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2005-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-04-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-08-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06114056",
        "briefTitle": "A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-01-22"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-11-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-01-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "West China Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01125709",
        "briefTitle": "Comparative Study of Clinical Endpoint in DMD: Handheld Myometry (HHM) Versus CINRG Quantitative Measurement System (CQMS)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-05-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-01-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05166109",
        "briefTitle": "A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-07-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-12-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-08-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ReveraGen BioPharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03531788",
        "briefTitle": "Use of Dynamic Arm Supports to Promote Activities of Daily Living in Individuals With DMD"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-08-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-02-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Roxanna Marie Bendixen"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04529707",
        "briefTitle": "Sleep Intervention in Young Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-02-17"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-08-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Pittsburgh"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06597656",
        "briefTitle": "A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-09-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-09-19"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01247207",
        "briefTitle": "Study of Ataluren in Previously Treated Participants With Nonsense Mutation Dystrophinopathy (nmDBMD)"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2010-11-30"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-11-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03433807",
        "briefTitle": "Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "NO_LONGER_AVAILABLE",
        "studyFirstPostDateStruct": {
          "date": "2018-02-15"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-04-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "EXPANDED_ACCESS"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01603407",
        "briefTitle": "Finding the Optimum Regimen for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-05-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-08-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Rochester"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03796637",
        "briefTitle": "A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) Who Have Been Treated With Ataluren"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2019-04-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-01-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-04-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05209087",
        "briefTitle": "Effects of Parental Influence on Physical Activity Level and Participation in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-03-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-01-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05066633",
        "briefTitle": "The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-08-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-10-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-10-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Medical University of Gdansk"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06100887",
        "briefTitle": "Phase 2 Study of EDG-5506 in Children and Adolescents with Duchenne Muscular Dystrophy Previously Treated with Gene Therapy (FOX)"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-03-22"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-10-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-09-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Edgewise Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02439216",
        "briefTitle": "Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-05-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-09-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catabasis Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01874275",
        "briefTitle": "Duchenne Muscular Dystrophy Clinical Trial"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-06-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Alan Neuromedical Technologies, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03439670",
        "briefTitle": "A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-06-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-02-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-03-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ReveraGen BioPharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02847975",
        "briefTitle": "Sodium Nitrate to Improve Blood Flow"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-07-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-08-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00606775",
        "briefTitle": "The Preventive Efficacy of Carvedilol on Cardiac Dysfunction in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2007-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-02-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2008-02-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Suzuka Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Cardiomyopathies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01999075",
        "briefTitle": "Stacking Exercises Aid the Decline in FVC and Sick Time"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-12-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-12-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Children's Hospital of Eastern Ontario"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03603288",
        "briefTitle": "Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2018-07-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-07-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-03"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Santhera Pharmaceuticals"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06054971",
        "briefTitle": "NSAA NON-Interventional Study Protocol"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-10-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-09-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Red Nucleus Enterprise Solutions, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00104078",
        "briefTitle": "Study Evaluating MYO-029 in Adult Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2005-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-02-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2007-12-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Wyeth is now a wholly owned subsidiary of Pfizer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy",
          "Facioscapulohumeral Muscular Dystrophy",
          "Limb-Girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05849688",
        "briefTitle": "Bicycle Training on Ventilatory Functions in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "NOT_YET_RECRUITING",
        "startDateStruct": {
          "date": "2023-05-15"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-05-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-05-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Beni-Suef University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00264888",
        "briefTitle": "Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2005-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-12-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2009-01-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06280209",
        "briefTitle": "A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-01-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-02-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "BioMarin Pharmaceutical"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04179409",
        "briefTitle": "A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of AMONDYS 45, EXONDYS 51, VYONDYS 53 in Subjects With DuchenneMuscular Dystrophy Carrying Eligible DMD Duplications."
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2020-02-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-11-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-10-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Kevin Flanigan"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00018109",
        "briefTitle": "A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glutamine and Creatine Monohydrate in Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "studyFirstPostDateStruct": {
          "date": "2001-07-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2005-06-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "National Center for Research Resources (NCRR)"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02069756",
        "briefTitle": "The Duchenne Registry"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2007-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-02-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-09-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "The Duchenne Registry"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01540409",
        "briefTitle": "Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2012-02-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-02-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-03-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03985878",
        "briefTitle": "A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2019-06-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-06-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-08-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01484678",
        "briefTitle": "Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2020-09-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-12-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Florida"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02246478",
        "briefTitle": "A Study of TAS-205 for Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-09-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-06-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Taiho Pharmaceutical Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03521271",
        "briefTitle": "Investigation Of Factors Affecting Hand Functions in Nonambulatory Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-04-05"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-05-11"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-05-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01070511",
        "briefTitle": "Tadalafil in Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-02-18"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-08-20"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04012671",
        "briefTitle": "A Registered Cohort Study on Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2019-07-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-07-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-03-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ning Wang, MD., PhD."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05661071",
        "briefTitle": "Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2022-05-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-12-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-12-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Hacettepe University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05967793",
        "briefTitle": "Effect of Kinesiology Taping on Head and Trunk Control in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-08-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Egyptian Chinese University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06274983",
        "briefTitle": "DMD- Interactive Virtual Reality Study"
      },
      "statusModule": {
        "overallStatus": "ACTIVE_NOT_RECRUITING",
        "startDateStruct": {
          "date": "2023-04-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-02-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sheffield Children's NHS Foundation Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02383511",
        "briefTitle": "Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-03-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-08-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Summit Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01126697",
        "briefTitle": "Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2010-02"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-05-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2018-06-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy",
          "Limb Girdle Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02667483",
        "briefTitle": "Study of DS-5141b in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-10"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-01-29"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-03-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Daiichi Sankyo Co., Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00844597",
        "briefTitle": "Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2009-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-02-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-10-06"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01963897",
        "briefTitle": "Duchenne Muscular Dystrophy < 18y in Norway: Genotype/Phenotype, Growth, Puberty, Bone Health and Quality of Life."
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-10-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-09-25"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Oslo University Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05641805",
        "briefTitle": "Physical Activity Level and Cognitive Functions in Children With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-11-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-12-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-02-09"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Mu\u015f Alparlan University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02851797",
        "briefTitle": "Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2017-06-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-08-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-02-02"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Italfarmaco"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02530905",
        "briefTitle": "Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-10-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-08-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-05-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02034305",
        "briefTitle": "Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-01-13"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-02-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Pittsburgh"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02571205",
        "briefTitle": "Testosterone Therapy for Pubertal Delay in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2015-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2015-10-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-04-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Newcastle-upon-Tyne Hospitals NHS Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06412328",
        "briefTitle": "Psychoeducation Program for Parents of Children With DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2023-06-21"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-05-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-05-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Lokman Hekim \u00dcniversitesi"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Psychoeducation",
          "Parents",
          "Psychological Wellness",
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02810028",
        "briefTitle": "Acceptance and Commitment Therapy for Muscle Disease"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-06-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-08-22"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "King's College Hospital NHS Trust"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscle Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05249361",
        "briefTitle": "Correlation Between Functional Capacity and Functional Capability in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2023-05-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-02-21"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-11-29"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Samsung Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00720161",
        "briefTitle": "Metformin in Children With Motor Deficit"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2006-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-07-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-06-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Universitaire Ziekenhuizen KU Leuven"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Spina Bifida",
          "Neuromuscular Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT06485661",
        "briefTitle": "Effect of Captopril on GLS in Duchenne Myodystrophy"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2024-01-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2024-07-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-07-16"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Ain Shams University"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Effect of Drug"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00016653",
        "briefTitle": "Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2000-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2001-05-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2",
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03963453",
        "briefTitle": "Regular Physical Exercise in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2021-02-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2019-05-24"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-03-01"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Haukeland University Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02760277",
        "briefTitle": "An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-07-28"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-05-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-07-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "ReveraGen BioPharma, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02286947",
        "briefTitle": "Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2014-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2014-11-10"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-03-30"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02653833",
        "briefTitle": "The Study of Skeletal Muscle Blood Flow in Becker Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2017-11-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-01-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-01-14"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cedars-Sinai Medical Center"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "EARLY_PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04740554",
        "briefTitle": "Heart Rate Variability in Individuals With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-03-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2021-02-05"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-02-05"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Sao Paulo"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02020954",
        "briefTitle": "Prospective Becker-Heart-Study"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2013-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-12-25"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-03-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Karim WAHBI"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Dilated Cardiomyopathy",
          "Lef Ventricular Dysfunction",
          "Heart Failure"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01826487",
        "briefTitle": "Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2013-03-26"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-08-04"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Muscular Dystrophies",
          "Muscular Disorders, Atrophic",
          "Muscular Diseases",
          "Musculoskeletal Diseases",
          "Neuromuscular Diseases",
          "Nervous System Diseases",
          "Genetic Diseases, X-Linked",
          "Genetic Diseases, Inborn"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01823783",
        "briefTitle": "Endomysial Fibrosis, Muscular Inflammatory Response and Calcium Homeostasis Dysfunction in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2012-11-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-04-04"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-02-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University Hospital, Montpellier"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Distrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05524883",
        "briefTitle": "Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-08-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-09-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Dyne Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03642145",
        "briefTitle": "A Study of Deflazacort (Emflaza\u00ae) in Participants With Duchenne Muscular Dystrophy (DMD)"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2018-10-31"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-08-22"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-06-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05712447",
        "briefTitle": "Duchenne Muscular Dystrophy Video Assessment Registry"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-09-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-02-03"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-12-18"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "The Emmes Company, LLC"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03002298",
        "briefTitle": "Virtual Reality in Individuals With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-12-23"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-04-11"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "University of Sao Paulo"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01890798",
        "briefTitle": "Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol"
      },
      "statusModule": {
        "overallStatus": "WITHDRAWN",
        "startDateStruct": {
          "date": "2014-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2013-07-02"
        },
        "lastUpdatePostDateStruct": {
          "date": "2014-03-24"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01645098",
        "briefTitle": "Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-08"
        },
        "studyFirstPostDateStruct": {
          "date": "2012-07-20"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-02-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Nationwide Children's Hospital"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00592553",
        "briefTitle": "Phase 2B Study of PTC124 (Ataluren) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2008-02-29"
        },
        "studyFirstPostDateStruct": {
          "date": "2008-01-14"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-04-07"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "PTC Therapeutics"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00102453",
        "briefTitle": "Pentoxifylline in Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2002-03"
        },
        "studyFirstPostDateStruct": {
          "date": "2005-01-31"
        },
        "lastUpdatePostDateStruct": {
          "date": "2011-10-27"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Cooperative International Neuromuscular Research Group"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT02964377",
        "briefTitle": "Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2016-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2016-11-16"
        },
        "lastUpdatePostDateStruct": {
          "date": "2021-12-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Craig McDonald, MD"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1",
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT03508947",
        "briefTitle": "Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-01-24"
        },
        "studyFirstPostDateStruct": {
          "date": "2018-04-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2019-04-08"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Wave Life Sciences Ltd."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE1"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01480245",
        "briefTitle": "Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2011-09"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-11-28"
        },
        "lastUpdatePostDateStruct": {
          "date": "2017-03-23"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "GlaxoSmithKline"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophies"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05516745",
        "briefTitle": "E-monitoring of PULMonary Function in Patients With Duchenne Muscular Dystrophy at Home\""
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2021-03-20"
        },
        "studyFirstPostDateStruct": {
          "date": "2022-08-26"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-08-26"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Medical University of Gdansk"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy (DMD)"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04669847",
        "briefTitle": "The Effects of Trunk Exercises on Upper Extremity and Respiratory Functions in DMD"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2018-04-07"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-12-17"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-12-17"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Gokce Yagmur Gunes Gencer"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne",
          "Upper Extremity",
          "Respiratory Functions"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "NA"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00819845",
        "briefTitle": "Ramipril Versus Carvedilol in Duchenne and Becker Patients"
      },
      "statusModule": {
        "overallStatus": "UNKNOWN",
        "startDateStruct": {
          "date": "2008-12"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-01-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2016-01-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Catholic University, Italy"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE4"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00312247",
        "briefTitle": "Biomechanical Analysis of Gait in Individuals With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2006-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2006-04-07"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-19"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Shriners Hospitals for Children"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01099761",
        "briefTitle": "Study of ACE-031 in Subjects With Duchenne Muscular Dystrophy"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2010-04"
        },
        "studyFirstPostDateStruct": {
          "date": "2010-04-08"
        },
        "lastUpdatePostDateStruct": {
          "date": "2022-10-13"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05967351",
        "briefTitle": "A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study"
      },
      "statusModule": {
        "overallStatus": "ENROLLING_BY_INVITATION",
        "startDateStruct": {
          "date": "2023-09-27"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-08-01"
        },
        "lastUpdatePostDateStruct": {
          "date": "2024-10-21"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Sarepta Therapeutics, Inc."
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT01350154",
        "briefTitle": "Effect of Modulating the nNOS System on Cardiac, Muscular and Cognitive Function in Becker Muscular Dystrophy Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2011-11"
        },
        "studyFirstPostDateStruct": {
          "date": "2011-05-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2013-04-10"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Rigshospitalet, Denmark"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Becker Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE2"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT04384354",
        "briefTitle": "Digestive Events in Duchenne Muscular Dystrophy Patients"
      },
      "statusModule": {
        "overallStatus": "COMPLETED",
        "startDateStruct": {
          "date": "2007-01"
        },
        "studyFirstPostDateStruct": {
          "date": "2020-05-12"
        },
        "lastUpdatePostDateStruct": {
          "date": "2020-05-12"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Centre d'Investigation Clinique et Technologique 805"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT00839033",
        "briefTitle": "Evaluation of a Mechanical Device During Acute Respiratory Failure in Patients With Neuromuscular Disorders"
      },
      "statusModule": {
        "overallStatus": "TERMINATED",
        "startDateStruct": {
          "date": "2009-06"
        },
        "studyFirstPostDateStruct": {
          "date": "2009-02-09"
        },
        "lastUpdatePostDateStruct": {
          "date": "2015-05-28"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Assistance Publique - H\u00f4pitaux de Paris"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Duchenne Muscular Dystrophy",
          "Amyotrophic Lateral Sclerosis",
          "Neuromuscular Diseases"
        ]
      },
      "designModule": {
        "studyType": "INTERVENTIONAL",
        "phases": [
          "PHASE3"
        ]
      }
    }
  },
  {
    "protocolSection": {
      "identificationModule": {
        "nctId": "NCT05833633",
        "briefTitle": "Study of Genotype and Phenotype Characterization in Duchenne Muscular Dystrophy With Small Mutations"
      },
      "statusModule": {
        "overallStatus": "RECRUITING",
        "startDateStruct": {
          "date": "2022-03-18"
        },
        "studyFirstPostDateStruct": {
          "date": "2023-04-27"
        },
        "lastUpdatePostDateStruct": {
          "date": "2023-05-15"
        }
      },
      "sponsorCollaboratorsModule": {
        "leadSponsor": {
          "name": "Fondazione Policlinico Universitario Agostino Gemelli IRCCS"
        }
      },
      "conditionsModule": {
        "conditions": [
          "Muscular Dystrophy, Duchenne"
        ]
      },
      "designModule": {
        "studyType": "OBSERVATIONAL"
      }
    }
  }
]